CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
Nutritional Supplementdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00013923
NCT00013923Phase 2Completed
CompareCT.gov

A Nutritional Brain Metabolic Enhancer for Alzheimer Disease

National Institute on Aging (NIA)·interventional·Posted Apr 3, 2001·Updated Dec 11, 2009

In Brief

A Phase 2 clinical trial evaluating Nutritional Supplement for Alzheimer Disease. Completed, across 1 site.

Detailed Summary

The purpose of this study is to evaluate the effectiveness of a nutritional supplement that has been developed to improve the brain function of a patient with Alzheimer's disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer Disease
CountriesUnited States
CollaboratorsBurke Medical Research Institute

Timeline

Phase 2CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 3, 2001
Primary CompletionJun 1, 2005
TodayJul 2, 2026
Posted 25.2 years ago

Interventions

Nutritional Supplementdrug